Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Daniel P. Mulloy"'
Autor:
Gorav Ailawadi, Daniel P. Mulloy, James M. Isbell, John A. Kern, Irving L. Kron, Matthew L. Stone, Damien J. LaPar
Publikováno v:
The Annals of Thoracic Surgery. 98:1645-1652
Cardiac surgical reexploration is necessary in approximately 5% of all patients. However, the impact of routine, planned reexploration performed in the intensive care unit (ICU) remains poorly defined. This study evaluated postoperative outcomes afte
Autor:
Stephen W. Ely, Mark A. Groh, Daniel P. Mulloy, Jesse L. Madden, Gerard L. Champsaur, Oliver A. Binns
Publikováno v:
Journal of the American College of Cardiology. 73:120
Higher mortality in women than in men after isolated coronary artery bypass graft (CABG) procedures has been historically accepted. We have reviewed our continuous series of isolated CABG performed in a single institution providing all coronary inter
Publikováno v:
The Annals of Thoracic Surgery. 100:e1-e3
We report the case of a 46-year-old male patient with a history of cystic fibrosis who received bilateral lung transplantation from a donor who died secondary to complications of heparin-induced thrombocytopenia. Postoperatively, he exhibited transie
Autor:
Yunge Zhao, Ashish Sharma, Lucas G. Fernandez, Christine L. Lau, Irving L. Kron, Victor E. Laubach, Daniel P. Mulloy
Publikováno v:
The Annals of Thoracic Surgery. 95:1762-1767
Background Severe ischemia-reperfusion (IR) injury leads to primary graft dysfunction after lung transplantation. Adenosine receptors modulate inflammation after IR, and the adenosine A 3 receptor (A 3 R) is expressed in lung tissue and inflammatory
Autor:
Matthew L. Stone, Bradley M. Rodgers, Sara K. Rasmussen, Eugene D. McGahren, Daniel P. Mulloy, Damien J. LaPar, Bartholomew J. Kane
Publikováno v:
Journal of Pediatric Surgery. 48:81-87
Current healthcare reform efforts have highlighted the potential impact of insurance status on patient outcomes. The influence of primary payer status (PPS) within the pediatric surgical patient population remains unknown. The purpose of this study w
Autor:
Daniel P. Mulloy, Irving L. Kron
Publikováno v:
Functional Mitral and Tricuspid Regurgitation ISBN: 9783319435084
Surgical treatment of ischemic mitral regurgitation with reduction ring annuloplasty is the current standard of practice, yet recurrence in a third of patients limits the benefit of this approach. In an effort to improve outcomes, attention has turne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08f7297ec84270839464a0aeafc97cea
https://doi.org/10.1007/978-3-319-43510-7_10
https://doi.org/10.1007/978-3-319-43510-7_10
Autor:
Ravi K. Ghanta, Daniel P. Mulloy, D. Scott Lim, Mike Saji, Michael Ragosta, Gorav Ailawadi, Walter J. Hoyt
Publikováno v:
Pediatric cardiology. 37(5)
Autor:
Irving L. Kron, Daniel P. Mulloy, Ivan K. Crosby, Damien J. LaPar, Ashish Sharma, Christine L. Lau, David V. Webb, Victor E. Laubach, Matthew L. Stone
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 144(5):1208-1216
Objectives Ex vivo lung perfusion (EVLP) is a promising modality for the evaluation and treatment of marginal donor lungs. The optimal timing of EVLP initiation and the potential for rehabilitation of donor lungs with extended warm ischemic times is
Autor:
Christine L. Lau, Matthew L. Stone, Gorav Ailawadi, Ivan K. Crosby, Damien J. LaPar, Daniel P. Mulloy, Irving L. Kron
Publikováno v:
The Annals of Thoracic Surgery. 94:52-58
Mitral valve (MV) disease is often accompanied by concomitant tricuspid valve (TV) disease. This study determined the influence of performing TV procedures in the setting of MV operations within a multiinstitutional patient population.From 2001 to 20
Autor:
Damien J. LaPar, D. Scott Lim, Gorav Ailawadi, Daniel P. Mulloy, Irving L. Kron, Ivan K. Crosby, John A. Kern
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 143:S12-S16
Objective The emergence of transcatheter approaches to mitral valve (MV) repair has focused attention on outcomes after surgical MV repair. Results from the EVEREST II trial demonstrated worse short-term major adverse event (MAE) rates for surgical r